Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a loss of -6.47%.However, over the last six months, we can see a stronger performance of -1.75%. Over the last 30 days, the price of ABBV has leaped by -0.73%. And in the last five days, it has surged by 3.81%.
At present, AbbVie Inc. (ABBV) has a stock price of $151.16. In the previous session, the stock saw a rise, peaking at $152.40 after an opening price of $149.42. The day’s lowest price was $149.05, and it closed at $149.27.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
AbbVie Inc. ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $168.11 on 01/06/23, while the lowest value for the same period was recorded at $130.96 on 06/28/23.
52-week price history of ABBV Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. AbbVie Inc.’s current trading price is -10.08% away from its 52-week high, while its distance from the 52-week low is 15.42%. The stock’s price range during this time has been between $130.96 and $168.11. The trading volume for the Healthcare sector company’s shares reached about 5.95 million for the day, which was higher than the average daily volume of 5.18 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
AbbVie Inc. (ABBV) has experienced a quarterly rise of 9.29% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 266.61B and boasts a workforce of 50000 employees.
AbbVie Inc.: Analysts’ Ratings Unveiled
As of right now, 14 analysts are rating AbbVie Inc. as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 15 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 144.09, with a change in price of -10.58. Similarly, AbbVie Inc. recorded 5,430,515 in trading volume during the last 100 days, posting a change of -6.54%.
ABBV’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ABBV stands at 4.74. Similarly, the long-term debt-to-equity ratio is also 4.34.
ABBV Stock Stochastic Average
Today, AbbVie Inc.’s raw stochastic average for the past 50 days stands at 88.33%, indicating a rise from the raw stochastic average of the last 20 days, which was 75.25%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 61.70% and 56.47% respectively.
